For St. Louis Park residents, the nearest obesity specialist may be a long drive away. Zepbound® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved since 2023 for Chronic weight management. Weight Method offers a separate program: licensed Minnesota providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month, including the provider evaluation, the medication, ongoing care, and shipping to St. Louis Park.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · St. Louis Park is already seeing results
GLP-1 weight-loss treatment available to eligible patients in St. Louis Park, MN. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Zepbound® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2023. Weight Method is a separate program: licensed providers in Minnesota evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible St. Louis Park, MN residents starts at $329/month.
Suburban life around St. Louis Park comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Tirzepatide therapy addresses biology involved in weight regulation by reducing hunger signals, so St. Louis Park area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy, at $329/month, delivered to your door. Compounded Tirzepatide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Minnesota and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.